Abstract
A six-week placebo-controlled trial of theefficacy and safety of 6 g per day of 4-aminosalicylicacid (4-ASA) was conducted in 30 subjects with mild tomoderately severe ulcerative colitis. Subjects were stratified into groups having distal (<60cm) or more extensive (>60 cm) disease. Diarrhea,bleeding, sigmoidoscopic and biopsy appearance, andphysician global assessment were scored to judgeefficacy. Safety was evaluated by monitoring untowardsymptoms and laboratory values. Median percentimprovement was significantly greater (P < 0.05) inthe 4-ASA 60-cm group (42.7%) than in the placebo 60-cmgroup (21.2%), but 4-ASA was not better than placebofor the 60-cm group or the total study group. Severedyspepsia (one subject), abnormal AST (transient infive, persistent in one) and elevated lipase without pancreatitis (six subjects) were noted. Thus 6g 4-ASA for six weeks was more effective than placebo inmild to moderate ulcerative colitis extending more than60 cm above the anus, but not in distal disease, and the drug was generally welltolerated.
Similar content being viewed by others
REFERENCES
Peskar BM, Coersmeier CH: Effect of antiinflammatory drugs on human colonic leukotriene formation. In Inflammatory Bowel Diseases, Basic Research and Clinical Implications. H Goebell, BM Peskar, H Malchow (eds). Boston, MTP Press, 1988, pp 153–159
Allgayer H, Rang S, Hofer P, Kruls W, Retey J, Gugler R: Superoxide radical (O2) inhibition by sulfasalazine (SAZ) and aminosalicylates: Extra-vs intracellular action. Gastroenterology 100:A556, 1991
Selby WS, Bennett MK, Jewell DP: Topical treatment of distal ulcerative colitis with 4-aminosalicylic acid enemas. Digestion 29:231–234, 1984
Ginsberg AL, Beck LS, McIntosh TM, Nochomovitz LE: Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind placebo-controlled trial. Ann Intern Med 108:195–199, 1988
Gandolfo J, Farthing M, Powers G, Eagen K, Goldberg M, Berman P, Kaplan M: 4-Aminosalicylic acid retention enemas in treatment of distal colitis. Dig Dis Sci 32:700–704, 1987
Campieri M, Lanfranchi GA, Bertoni F, Brignola AC, Bazzocchi G, Minguzzi MR, Labo G: A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicyclic in topical treatment of ulcerative colitis. Digestion 29:204–208, 1984
Nagy F, Karacsony G, Varro V: Experience with topical administration of 4-aminosalicylic acid in ulcerative colitis. Dis Colon Rectum 32:134–137, 1989
O'Donnell LJD, Arvind AS, Cameron D, Hoang P, Talbot IC, Jewell DP, Lennard-Jones JE, Farthing MJG: 4-Aminosalicylic acid enemas are as effective as prednisolone enemas in distal ulcerative colitis. Gastroenterology 98:A195, 1990
Ginsberg AL, Davis ND, Nochamovitz LE: Placebo-controlled, double-blind trial of oral 4-aminosalicylic acid in ulcerative colitis. Gastroenterology 98:A172, 1990
Nasr B, Bigelow J, Roff N, Beeken W: Luminal concentrations of orally ingested 4-ASA as determined by in vivo equilibrium dialysis. Aliment Pharmacol Ther 4:583–592, 1990
Schroeder KW, Tremaine WJ, Ilstrup DM: Coated oral 5-aminosalicyclic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317:1625–1629, 1987
Lauritsen K, Hansen J, Ryde M, Rask-Madsen J: Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis. Gastroenterology 86:1496–1500, 1984
Willoughby CP, Piris J, Truelove SC: The effect of topical N-acetyl 5-aminosalicylic acid in ulcerative colitis. Scand J Gastroenterol 15:715–719, 1980
Binder V, Halskov S, Hvidberg E, Aristensen E, Riis P, Tougaard L, Willumsen L: A controlled study of 5-acetaminosalicylic acid (5-AC-ASA) as enema in ulcerative colitis. Scand J Gastroenterol 16:1122, 1981 (abstract)
Rights and permissions
About this article
Cite this article
Beeken, W., Howard, D., Bigelow, J. et al. Controlled Trial of 4-ASA in Ulcerative Colitis. Dig Dis Sci 42, 354–358 (1997). https://doi.org/10.1023/A:1018874120749
Issue Date:
DOI: https://doi.org/10.1023/A:1018874120749